Notably, in comparison to the potent anti-HIV and -KS activities of IFNα and β, the lack of anti-HIV/AIDS activities of IFNγ greatly reduced the enthusiasm toward IFNγ and therapeutic focus shifted to IFNα as therapy against HIV/AIDS (57). This evidence concerns the gene IFNG and AIDS.